Eicosapentaenoic acid suppresses adverse effects of C-reactive protein overexpression on pressure overload-induced cardiac remodeling

[1]  永井 利幸.  C-reactive protein overexpression exacerbates pressure overload-induced cardiac remodeling through enhanced inflammatory response , 2012 .

[2]  N. Frangogiannis,et al.  Transforming growth factor (TGF)-β signaling in cardiac remodeling. , 2011, Journal of molecular and cellular cardiology.

[3]  K. Fukuda,et al.  C-Reactive Protein Overexpression Exacerbates Pressure Overload–Induced Cardiac Remodeling Through Enhanced Inflammatory Response , 2011, Hypertension.

[4]  Y. Kihara,et al.  Effects of lipid-lowering therapy with strong statin on serum polyunsaturated fatty acid levels in patients with coronary artery disease , 2011, Heart and Vessels.

[5]  S. Kusachi,et al.  Association of serum levels of arachidonic acid and eicosapentaenoic acid with prevalence of major adverse cardiac events after acute myocardial infarction , 2011, Heart and Vessels.

[6]  C. Lau,et al.  C-Reactive Protein Promotes Cardiac Fibrosis and Inflammation in Angiotensin II-Induced Hypertensive Cardiac Disease , 2010, Hypertension.

[7]  K. O’Shea,et al.  omega-3 polyunsaturated fatty acid supplementation for the treatment of heart failure: mechanisms and clinical potential. , 2009, Cardiovascular research.

[8]  A. Ferreira,et al.  Prognostic value of high-sensitivity C-reactive protein in heart failure: a systematic review. , 2009, Journal of cardiac failure.

[9]  W. Harris,et al.  Fish oil, but not flaxseed oil, decreases inflammation and prevents pressure overload-induced cardiac dysfunction. , 2009, Cardiovascular research.

[10]  Gissi-Hf Investigators.  Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial , 2008, The Lancet.

[11]  L. Tavazzi,et al.  ect of n-3 polyunsaturated fatty acids in patients with chronic heart failure ( the GISSI-HF trial ) : a randomised , double-blind , placebo-controlled trial , 1980 .

[12]  W. Kop,et al.  Dietary supplementation with omega-3 PUFA increases adiponectin and attenuates ventricular remodeling and dysfunction with pressure overload. , 2007, Cardiovascular research.

[13]  A. Hofman,et al.  C-reactive protein and risk of heart failure. The Rotterdam Study. , 2006, American heart journal.

[14]  K. Aonuma,et al.  Eicosapentaenoic acid prevents endothelin-1-induced cardiomyocyte hypertrophy in vitro through the suppression of TGF-beta 1 and phosphorylated JNK. , 2006, American journal of physiology. Heart and circulatory physiology.

[15]  S. Verma,et al.  Is C-reactive protein an innocent bystander or proatherogenic culprit? C-reactive protein promotes atherothrombosis. , 2006, Circulation.

[16]  D. Moser,et al.  Dietary fat intake and proinflammatory cytokine levels in patients with heart failure. , 2005, Journal of cardiac failure.

[17]  D. Mozaffarian,et al.  Fish intake and risk of incident heart failure. , 2005, Journal of the American College of Cardiology.

[18]  S. Ogawa,et al.  Serum C-reactive protein elevation in left ventricular remodeling after acute myocardial infarction--role of neurohormones and cytokines. , 2003, International journal of cardiology.

[19]  S. Ogawa,et al.  C-reactive protein as a predictor of infarct expansion and cardiac rupture after a first Q-wave acute myocardial infarction. , 1997, Circulation.